Bulk Manufacturer of Controlled Substances Application: Bulk Manufacturer of Marihuana: GGGYI LLC, 11328-11329 [2021-03754]

Download as PDF 11328 Federal Register / Vol. 86, No. 35 / Wednesday, February 24, 2021 / Notices Anthropology. The human remains are a shovel shaped incisor with a groove between the enamel and the tooth root. No known individual was identified. No associated funerary objects are present. Museum records indicate that the Buick Camp Site represents a High Plains Upper Republican occupation. Radiocarbon analysis dates the Buick Camp Site to 664–770 A.D., which corresponds to the Plains Woodland Period. Archeologists identify the Upper Republican culture as ancestral Pawnee. Elbert County is within the cultural landscape of the Pawnee Nation. Based on archeological and historical evidence, the Buick Camp Site was situated in an area where bison were harvested at least bi-annually. Determinations Made by the University of Denver Museum of Anthropology Officials of the University of Denver Museum of Anthropology have determined that: • Pursuant to 25 U.S.C. 3001(9), the human remains described in this notice represent the physical remains of one individual of Native American ancestry. • Pursuant to 25 U.S.C. 3001(2), there is a relationship of shared group identity that can be reasonably traced between the Native American human remains and the Pawnee Nation of Oklahoma. khammond on DSKJM1Z7X2PROD with NOTICES Additional Requestors and Disposition Lineal descendants or representatives of any Indian Tribe or Native Hawaiian organization not identified in this notice that wish to request transfer of control of these human remains should submit a written request with information in support of the request to Anne Amati, University of Denver Museum of Anthropology, 2000 E Asbury Avenue, Sturm Hall 146, Denver, CO 80208, telephone (303) 871–2687, email anne.amati@du.edu, by March 26, 2021. After that date, if no additional requestors have come forward, transfer of control of the human remains to the Pawnee Nation of Oklahoma may proceed. The University of Denver Museum of Anthropology is responsible for notifying the Pawnee Nation of Oklahoma and The Invited Tribes that this notice has been published. Dated: February 5, 2021. Melanie O’Brien, Manager, National NAGPRA Program. [FR Doc. 2021–03716 Filed 2–23–21; 8:45 am] BILLING CODE 4312–52–P VerDate Sep<11>2014 17:21 Feb 23, 2021 Jkt 253001 DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–797] Bulk Manufacturer of Controlled Substances Application: Bulk Manufacturer of Marihuana: AJC Industries, Inc. Drug Enforcement Administration, Justice. ACTION: Notice of application. AGENCY: The Drug Enforcement Administration (DEA) is providing notice of an application it has received from an entity applying to be registered to manufacture in bulk basic class(es) of controlled substances listed in schedule I. DEA intends to evaluate this and other pending applications according to its regulations governing the program of growing marihuana for scientific and medical research under DEA registration. SUMMARY: Registered bulk manufacturers of the affected basic class(es), and applicants therefor, may file written comments on or objections to the issuance of the proposed registration on or before April 26, 2021. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW 8701 Morrissette Drive, Springfield, Virginia 22152. To ensure proper handling of comments, please reference Docket No. DEA–797 in all correspondence, including attachments. SUPPLEMENTARY INFORMATION: The Controlled Substances Act (CSA) prohibits the cultivation and distribution of marihuana except by persons who are registered under the CSA to do so for lawful purposes. In accordance with the purposes specified in 21 CFR 1301.33(a), DEA is providing notice that the entity identified below has applied for registration as a bulk manufacturer of schedule I controlled substances. In response, registered bulk manufacturers of the affected basic class(es), and applicants therefor, may file written comments on or objections of the requested registration, as provided in this notice. This notice does not constitute any evaluation or determination of the merits of the application submitted. The applicant plans to manufacture bulk active pharmaceutical ingredients (APIs) for product development and distribution to DEA-registered researchers. If the application for registration is granted, the registrant would not be authorized to conduct DATES: PO 00000 Frm 00112 Fmt 4703 Sfmt 4703 other activity under this registration aside from those coincident activities specifically authorized by DEA regulations. DEA will evaluate the application for registration as a bulk manufacturer for compliance with all applicable laws, treaties, and regulations and to ensure adequate safeguards against diversion are in place. As this applicant has applied to become registered as a bulk manufacturer of marihuana, the application will be evaluated under the criteria of 21 U.S.C. 823(a). DEA will conduct this evaluation in the manner described in the rule published at 85 FR 82333 on December 18, 2020, and reflected in DEA regulations at 21 CFR part 1318. In accordance with 21 CFR 1301.33(a), DEA is providing notice that on January 14, 2021, AJC Industries Inc., 19469 County Road H, Ordway, Colorado 81063–9739, applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substances: Controlled substance Marihuana extraxt ........... Marihuana ....................... Drug code Schedule 7350 7360 I I William T. McDermott, Assistant Administrator. [FR Doc. 2021–03755 Filed 2–23–21; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–794] Bulk Manufacturer of Controlled Substances Application: Bulk Manufacturer of Marihuana: GGGYI LLC Drug Enforcement Administration, Justice. ACTION: Notice of application. AGENCY: The Drug Enforcement Administration (DEA) is providing notice of an application it has received from an entity applying to be registered to manufacture in bulk basic class(es) of controlled substances listed in schedule I. DEA intends to evaluate this and other pending applications according to its regulations governing the program of growing marihuana for scientific and medical research under DEA registration. SUMMARY: E:\FR\FM\24FEN1.SGM 24FEN1 11329 Federal Register / Vol. 86, No. 35 / Wednesday, February 24, 2021 / Notices Registered bulk manufacturers of the affected basic class(es), and applicants therefor, may file written comments on or objections to the issuance of the proposed registration on or before April 26, 2021. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW 8701 Morrissette Drive, Springfield, Virginia 22152. To ensure proper handling of comments, please reference Docket No. DEA–794 in all correspondence, including attachments. SUPPLEMENTARY INFORMATION: The Controlled Substances Act (CSA) prohibits the cultivation and distribution of marihuana except by persons who are registered under the CSA to do so for lawful purposes. In accordance with the purposes specified in 21 CFR 1301.33(a), DEA is providing notice that the entity identified below has applied for registration as a bulk manufacturer of schedule I controlled substances. In response, registered bulk manufacturers of the affected basic class(es), and applicants therefor, may file written comments on or objections of the requested registration, as provided in this notice. This notice does not constitute any evaluation or determination of the merits of the application submitted. The applicant plans to manufacture bulk active pharmaceutical ingredients (APIs) for product development and distribution to DEA-registered researchers. If the application for registration is granted, the registrant would not be authorized to conduct other activity under this registration aside from those coincident activities DATES: specifically authorized by DEA regulations. DEA will evaluate the application for registration as a bulk manufacturer for compliance with all applicable laws, treaties, and regulations and to ensure adequate safeguards against diversion are in place. As this applicant has applied to become registered as a bulk manufacturer of marihuana, the application will be evaluated under the criteria of 21 U.S.C. 823(a). DEA will conduct this evaluation in the manner described in the rule published at 85 FR 82333 on December 18, 2020, and reflected in DEA regulations at 21 CFR part 1318. In accordance with 21 CFR 1301.33(a), DEA is providing notice that on January 25, 2021, GGGYI LLC, 4168 South Drexel Boulevard 2A, Chicago, Illinois 60653, applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substances: Controlled substance Drug code Marihuana Extract ................... Marihuana ............................... Tetrahydrocannabinols ........... 7350 7360 7370 Schedule I I I William T. McDermott, Assistant Administrator. [FR Doc. 2021–03754 Filed 2–23–21; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–770] Bulk Manufacturer of Controlled Substances Application: Sigma Aldrich Research Biochemicals, Inc Drug Enforcement Administration, Justice. ACTION: Notice of application. AGENCY: Sigma Aldrich Research Biochemicals, Inc, has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information. DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before April 26, 2021. Such persons may also file a written request for a hearing on the application on or before April 26, 2021. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUMMARY: In accordance with 21 CFR 1301.33(a), this is notice that on December 17, 2020, Sigma Aldrich Research Biochemicals, Inc, 400–600 Summit Drive, Burlington, Massachusetts 01803, applied to be registered as a bulk manufacturer of the following basic classes of controlled substances: SUPPLEMENTARY INFORMATION: khammond on DSKJM1Z7X2PROD with NOTICES Controlled substance Drug code Cathinone ........................................................................................................................................................................ 4-Methyl-N-Methylcathinone ............................................................................................................................................ Methaqualone .................................................................................................................................................................. JWH-018 & AM678 .......................................................................................................................................................... Lysergic Acid Diethylamide ............................................................................................................................................. Tetrahydrocannabinols .................................................................................................................................................... Mescaline ......................................................................................................................................................................... 3,4-Methylenedioxymethamphetamine ............................................................................................................................ Alpha-Methyltryptamine ................................................................................................................................................... Dimethyltryptamine .......................................................................................................................................................... 5-Methoxy-N,N-Diisopropyltryptamine ............................................................................................................................. 1-Benzylpiperazine .......................................................................................................................................................... 2-(2,5-Dimethoxyphenyl) Ethanamine ............................................................................................................................. 3,4-Methylenedioxypyrovalerone ..................................................................................................................................... 3,4-Methylenedioxy-N-Methylcathinone .......................................................................................................................... Heroin .............................................................................................................................................................................. Normorphine .................................................................................................................................................................... Norlevorphanol ................................................................................................................................................................ Amphetamine ................................................................................................................................................................... Methylphenidate .............................................................................................................................................................. Nabilone ........................................................................................................................................................................... Phencyclidine ................................................................................................................................................................... Cocaine ............................................................................................................................................................................ VerDate Sep<11>2014 17:21 Feb 23, 2021 Jkt 253001 PO 00000 Frm 00113 Fmt 4703 Sfmt 4703 E:\FR\FM\24FEN1.SGM 24FEN1 1235 1248 2565 7118 7315 7370 7381 7405 7432 7435 7439 7493 7517 7535 7540 9200 9313 9634 1100 1724 7379 7471 9041 Schedule I I I I I I I I I I I I I I I I I I II II II II II

Agencies

[Federal Register Volume 86, Number 35 (Wednesday, February 24, 2021)]
[Notices]
[Pages 11328-11329]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-03754]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-794]


Bulk Manufacturer of Controlled Substances Application: Bulk 
Manufacturer of Marihuana: GGGYI LLC

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: The Drug Enforcement Administration (DEA) is providing notice 
of an application it has received from an entity applying to be 
registered to manufacture in bulk basic class(es) of controlled 
substances listed in schedule I. DEA intends to evaluate this and other 
pending applications according to its regulations governing the program 
of growing marihuana for scientific and medical research under DEA 
registration.

[[Page 11329]]


DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefor, may file written comments on or objections to 
the issuance of the proposed registration on or before April 26, 2021.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW 8701 
Morrissette Drive, Springfield, Virginia 22152. To ensure proper 
handling of comments, please reference Docket No. DEA-794 in all 
correspondence, including attachments.

SUPPLEMENTARY INFORMATION: The Controlled Substances Act (CSA) 
prohibits the cultivation and distribution of marihuana except by 
persons who are registered under the CSA to do so for lawful purposes. 
In accordance with the purposes specified in 21 CFR 1301.33(a), DEA is 
providing notice that the entity identified below has applied for 
registration as a bulk manufacturer of schedule I controlled 
substances. In response, registered bulk manufacturers of the affected 
basic class(es), and applicants therefor, may file written comments on 
or objections of the requested registration, as provided in this 
notice. This notice does not constitute any evaluation or determination 
of the merits of the application submitted.
    The applicant plans to manufacture bulk active pharmaceutical 
ingredients (APIs) for product development and distribution to DEA-
registered researchers. If the application for registration is granted, 
the registrant would not be authorized to conduct other activity under 
this registration aside from those coincident activities specifically 
authorized by DEA regulations. DEA will evaluate the application for 
registration as a bulk manufacturer for compliance with all applicable 
laws, treaties, and regulations and to ensure adequate safeguards 
against diversion are in place.
    As this applicant has applied to become registered as a bulk 
manufacturer of marihuana, the application will be evaluated under the 
criteria of 21 U.S.C. 823(a). DEA will conduct this evaluation in the 
manner described in the rule published at 85 FR 82333 on December 18, 
2020, and reflected in DEA regulations at 21 CFR part 1318.
    In accordance with 21 CFR 1301.33(a), DEA is providing notice that 
on January 25, 2021, GGGYI LLC, 4168 South Drexel Boulevard 2A, 
Chicago, Illinois 60653, applied to be registered as a bulk 
manufacturer of the following basic class(es) of controlled substances:

------------------------------------------------------------------------
                                          Drug
          Controlled substance            code           Schedule
------------------------------------------------------------------------
Marihuana Extract......................    7350  I
Marihuana..............................    7360  I
Tetrahydrocannabinols..................    7370  I
------------------------------------------------------------------------


William T. McDermott,
Assistant Administrator.
[FR Doc. 2021-03754 Filed 2-23-21; 8:45 am]
BILLING CODE 4410-09-P